Covalon Technologies (CVALF) Expected to Announce Quarterly Earnings on Friday

Covalon Technologies (OTCMKTS:CVALF) is projected to announce its earnings results before the market opens on Friday, February 21st. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $6.37 million for the quarter.

Covalon Technologies (OTCMKTS:CVALF) last posted its earnings results on Tuesday, January 7th. The company reported $0.01 earnings per share (EPS) for the quarter. Covalon Technologies had a return on equity of 12.33% and a net margin of 8.58%.

Covalon Technologies Stock Performance

OTCMKTS CVALF opened at $2.11 on Monday. The business has a 50 day simple moving average of $2.25 and a 200 day simple moving average of $2.31. Covalon Technologies has a 52-week low of $0.74 and a 52-week high of $3.08. The stock has a market cap of $57.81 million, a price-to-earnings ratio of 30.15 and a beta of -0.29.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.